Serum amyloid A (SAA) is an acute-phase reactant mainly associated with high-density lipoproteins (1) but also with very-low-density lipoproteins (VLDLs) or low-density lipo-. proteins (2). On isofocusing, plasma SAA exhibits mainly two isoforms, SAA1 and SAA2. They differ in only one amino acid; SAA2 lacks the N-terminal arginine (3). hornozygous. lmmunoblotrevealedthat the prominentbend seenbeforeInthe apoE4position upon apoVLDL focusingconsisted of apoE4andSAA#{128}Q. The patternrevealedby Immunoblottlngwas found to be apo E413.Serum A also exhibited a bandin the apoE4 regionupon VLDL isoloaislng. Immunoblotting revealedthis bandas SM Apolipoprotein (apo) E is a polymorphic apolipoprotein with mainly three isoforms in plasma-E2, E3, and E4-that differ in cysteine and arginine content (4) and are coded for by three alleles #{128}2, #{128}3, and #{128}4. Six phenotypes can be distinguished-three homozygotes (E2/2, E3/3, and E4/4) and three heterozygotes (E2/3, EZ/4, and E3/4)-on isofocusing, mainly performed on urea-soluble apolipoproteins from VLDLs (5).
Technical Briefs (-300 words text) summarize findings that are of interest to a relatively limited audience.Readers desiring fuller details may obtain them by writing directly to the author(s) at the address given. In numerous clinical situations-e.g., chronic diarrhea, chronic cholestasis, and cystic fibrosis-phylloquinone (vitamm Kl(so)) absorption can be disturbed, in children as well as in adults. The reference interval for phylloquinone in serum of human adults has been described (1-4), but little is known about the reference interval for Kj() in serum of healthy children. We measured it in serum of 96 healthy children (40 girls, 56 boys), ages between two months and 19 years. All were Europeans, from various social levels. The In all subjects, coagulation, blood count, and results of liver tests were within normal limits. For quantitative analysis of phylloquinone in the serum samples we used a previously described HPLC procedure (3,
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The vitamin Kl(ro) values in the children did not follow a gaussian distribution, but an apparent log-normal distribution was confirmed by the Kolmogorov-Smirnov test. Analysis of these data indicated no age-or sexrelated differences.
Finally, we compared the reference interval as obtained for the healthy children population with the reference interval in healthy adults (3). For 50 healthy adults a log. hornozygous. lmmunoblotrevealedthat the prominentbend seenbeforeInthe apoE4position upon apoVLDL focusingconsisted of apoE4andSAA#{128}Q. The patternrevealedby Immunoblottlngwas found to be apo E413.Serum A also exhibited a bandin the apoE4 regionupon VLDL isoloaislng. Immunoblotting revealedthis bandas SM Apolipoprotein (apo) E is a polymorphic apolipoprotein with mainly three isoforms in plasma-E2, E3, and E4-that differ in cysteine and arginine content (4) and are coded for by three alleles #{128}2, #{128}3, and #{128}4. Six phenotypes can be distinguished-three homozygotes (E2/2, E3/3, and E4/4) and three heterozygotes (E2/3, EZ/4, and E3/4)-on isofocusing, mainly performed on urea-soluble apolipoproteins from VLDLs (5) .
We could demonstrate that coincident with a massive increase in serum amyloid A, the acute-phase proteins associate with VLDLs and are co-isolated with VLDLs by ultracentrifugation.
They are urea-soluble apolipoproteins and are separated by isoelectric focusing together with the usual VLDL apolipoproteins, SAA2 almost co-focusing with ape E4 with which it can thus be confused, leading to false phenotyping of apo E when protein staining is used to interpret the phenotypes. After Coomassie Blue staining, the SAA-containing VLDL may be looked at as an apo-E4-containing pattern. A more reliable procedure for discriminating the proteins focusing at the apo E4 position would seem to be the transfer of apolipoproteins, after isofocusing, to nitrocellulose sheets and their identification by use of specific antibodies to apo E. As shown in Figure 1 , ape E4 and SAA2 almost co-focus. In the Figure they are discriminated by specific antibodies both to apo E and SAA. Initially the VLDL phenotyped for apo E from lane B was seen with a pronounced band in the ape E4 position, interpreted as an apo E4 homozygous pattern.
Isofocusing of plasma and subsequent immunoblotting revealed that the band found in the apo E4 position consisted both of ape E4 and SAA (Figure 1, B, C) . The plasma was thus found to be ape E3/4
heterozygous. An additional component of the band is thus clearly identified as SAA2 by specific antibodies to SAA. In some other cases,ape E4 was reported when it actually was not present, e.g., in VLI)Ls from plasma in laneA of Figure  1 .
Recently Stuyt et al. (6) reported on the co-focusing with ape E4 of additional proteins in VLDL from patients with acute pancreatitis. Our results demonstrate that one of these co-focusing proteins can be serum amyloid A (isoform SAA2), which could help explain the different reports (7,8) on ape E4 frequencies in type V hyperlipoproteinemia.
We show here that immunological identification of apelipoproteins avoids the possible confusion of SAA2 with ape E4. We (9) and others (10), by setting up immunoblotting. procedures for phenotyping of ape E, have seen the possible confusion of the ape E pattern with serum amyloid A when ape VLDL protein staining is used to determine phenotypes instead of immunological detection. One should therefore be aware of this phenomenon when interpreting ape E phenotyping results and should always run an ape E4 standard when immunoblotting is not available.
